Purro Norbert,Smyth Mark,Goldman Erick,Wirth David D.
申请号:
NZ71382813
公开号:
NZ713828A
申请日:
2013.06.03
申请国别(地区):
NZ
年份:
2017
代理人:
摘要:
Described herein is the Bruton’s tyrosine kinase (Btk) inhibitor 1-((R)-3-(4-amino-3-(4-phenoxyphenyl)-1 H-pyrazolo [3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one, including crystalline forms, solvates and pharmaceutically acceptable salts thereof, as well as pharmaceutical compositions that include the Btk inhibitor and methods of using the Btk inhibitor in the treatment of diseases or conditions that would benefit from inhibition of Btk activity.